Filana Therapeutics (FLNA) EBT Margin (2010 - 2013)
Filana Therapeutics (FLNA) posted EBT Margin of 93.68% for Q4 2013, up 340.7% on a QoQ basis from 38.92% in Q3 2013, and up 16645.0% year-over-year from N/an in Q4 2012.
Powered by 
Analysis
Filana Therapeutics (FLNA) EBT Margin (2010 - 2013) Analysis & Trends
Filana Therapeutics has reported EBT Margin for 4 years, with the latest figure at 93.68% in Q4 2013.
- On a quarterly basis, EBT Margin rose 16645.0% year-over-year to 93.68% in Q4 2013; TTM through Dec 2013 was 76.71%, a 10836.0% increase from a year earlier, with the FY2013 full-year figure at 76.54%, up 10818.0% from the prior year.
- EBT Margin was 93.68% for Q4 2013 at Filana Therapeutics, up from 38.92% in the prior quarter.
- The five-year high for EBT Margin was 93.68% in Q4 2013, with the low at 118.75% in Q4 2010.
- Average EBT Margin over 4 years is 29.16%, with a median of 29.65% recorded in 2011.
- The sharpest annual moves came in 2012 and 2013: EBT Margin tumbled 5854 bps in 2012, then jumped 16645 bps in 2013.
- Over 4 years, EBT Margin stood at 118.75% in 2010, then surged by 88 bps to 14.23% in 2011, then sank by 411 bps to 72.77% in 2012, then soared by 229 bps to 93.68% in 2013.
- The last three EBT Margin figures came in at 93.68% (Q4 2013), 38.92% (Q3 2013), and 15.36% (Q2 2013), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 27.53% |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | -131.41% |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 41.75% |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 35.61% |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 35.78% |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | -528.97% |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 13.77% |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 4.84% |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | -20,427.46% |
| 10 | Filana Therapeutics | 38.14 Mn | 38.14 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2013 | 93.68% |
| Sep 30, 2013 | -38.92% |
| Jun 30, 2013 | -15.36% |
| Mar 31, 2013 | -20.84% |
| Dec 31, 2012 | -72.77% |
| Sep 30, 2012 | -56.88% |
| Jun 30, 2012 | -4.77% |
| Mar 31, 2012 | 1.01% |
| Dec 31, 2011 | -14.23% |
| Sep 30, 2011 | -29.65% |
| Jun 30, 2011 | -43.60% |
| Mar 31, 2011 | -14.80% |
| Dec 31, 2010 | -118.75% |
| Sep 30, 2010 | -54.30% |
| Jun 30, 2010 | -47.25% |